Futura Historical Cash Flow

FUM Stock   33.70  0.70  2.12%   
Analysis of Futura Medical cash flow over time is an excellent tool to project Futura Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 4.2 M or Depreciation of 136.8 K as it is a great indicator of Futura Medical ability to facilitate future growth, repay debt on time or pay out dividends.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Futura Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Futura Medical is a good buy for the upcoming year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Futura Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Futura Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Futura balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Futura's non-liquid assets can be easily converted into cash.

Futura Medical Cash Flow Chart

At present, Futura Medical's Change In Working Capital is projected to increase significantly based on the last few years of reporting. The current year's Begin Period Cash Flow is expected to grow to about 4.2 M, whereas Other Cashflows From Financing Activities is projected to grow to (1.4 M).

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Change To Inventory

The increase or decrease in the amount of inventory a company has over a certain period.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most accounts from Futura Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Futura Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Futura Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
At present, Futura Medical's Change In Working Capital is projected to increase significantly based on the last few years of reporting. The current year's Begin Period Cash Flow is expected to grow to about 4.2 M, whereas Other Cashflows From Financing Activities is projected to grow to (1.4 M).

Futura Medical cash flow statement Correlations

0.480.18-0.670.18-0.110.180.250.62-0.05-0.270.180.670.070.0-0.170.66
0.480.22-0.690.34-0.430.30.62-0.14-0.17-0.470.41-0.030.12-0.11-0.270.31
0.180.220.10.63-0.160.61-0.590.240.08-0.60.63-0.04-0.790.84-0.590.04
-0.67-0.690.10.010.150.02-0.650.140.310.04-0.01-0.18-0.350.27-0.03-0.45
0.180.340.630.01-0.130.95-0.380.080.06-0.950.980.0-0.140.22-0.93-0.11
-0.11-0.43-0.160.15-0.130.15-0.140.040.020.08-0.1-0.04-0.10.2-0.190.0
0.180.30.610.020.950.15-0.360.10.0-0.950.970.0-0.220.31-1.0-0.08
0.250.62-0.59-0.65-0.38-0.14-0.36-0.29-0.260.23-0.31-0.020.56-0.630.370.32
0.62-0.140.240.140.080.040.1-0.290.26-0.160.070.71-0.230.24-0.110.43
-0.05-0.170.080.310.060.020.0-0.260.260.0-0.020.030.050.080.0-0.04
-0.27-0.47-0.60.04-0.950.08-0.950.23-0.160.0-0.98-0.080.17-0.230.940.02
0.180.410.63-0.010.98-0.10.97-0.310.07-0.02-0.980.0-0.180.24-0.95-0.12
0.67-0.03-0.04-0.180.0-0.040.0-0.020.710.03-0.080.00.1-0.040.00.1
0.070.12-0.79-0.35-0.14-0.1-0.220.56-0.230.050.17-0.180.1-0.950.21-0.01
0.0-0.110.840.270.220.20.31-0.630.240.08-0.230.24-0.04-0.95-0.31-0.03
-0.17-0.27-0.59-0.03-0.93-0.19-1.00.37-0.110.00.94-0.950.00.21-0.310.08
0.660.310.04-0.45-0.110.0-0.080.320.43-0.040.02-0.120.1-0.01-0.030.08
Click cells to compare fundamentals

Futura Medical Account Relationship Matchups

Futura Medical cash flow statement Accounts

201920202021202220232024 (projected)
Change In Cash(6.6M)(1.5M)9.4M(6.3M)3.7M3.9M
Free Cash Flow(6.7M)(4.6M)(4.3M)(6.5M)(935.6K)(982.4K)
Change In Working Capital3.0M(4.0M)1.3M(511.5K)3.6M3.8M
Begin Period Cash Flow9.2M2.5M1.0M10.4M4.0M4.2M
Other Cashflows From Financing Activities(10.5K)(211.6K)(672.3K)(740.7K)(1.4M)(1.4M)
Depreciation20.7K25.0K19.8K24.7K130.3K136.8K
Other Non Cash Items(22.3K)(924.0)519.2K911.1K(71.8K)(68.2K)
Capital Expenditures32.7K8.4K419.7K740.7K1.5M1.6M
Total Cash From Operating Activities(6.7M)(4.5M)(3.9M)(5.8M)570.3K598.8K
Net Income(11.1M)(2.9M)(5.9M)(6.9M)(6.9M)(6.5M)
Total Cash From Financing Activities19.3K3.1M13.6M169.6K4.5M3.5M
End Period Cash Flow2.5M1.0M10.4M4.0M7.7M4.3M
Other Cashflows From Investing Activities19.3K27.6K22.3K924.0831.6790.02
Change To Inventory13.2K62.6K7.8K0.0(339.0)(322.05)
Change To Account Receivables204.9K61.4K(39.5K)(186.4K)(974.5K)(925.8K)
Stock Based Compensation101.4K149.4K181.8K671.9K2.7M2.9M
Total Cashflows From Investing Activities23.1K(10.5K)(7.4K)(419.7K)(377.8K)(358.9K)
Sale Purchase Of Stock220.8K5.9M19.3K3.3M2.9M3.4M
Change To Netincome(311.0K)(784.6K)1.9M(207.6K)(238.7K)(226.8K)
Change To Liabilities1.5M2.8M(4.1M)1.3M1.2M1.2M
Investments(10.5K)(7.4K)(419.7K)(740.7K)(1.4M)(1.4M)
Issuance Of Capital Stock19.3K3.3M14.3M169.6K4.5M5.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Futura Stock

The Cash Flow Statement is a financial statement that shows how changes in Futura balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Futura's non-liquid assets can be easily converted into cash.